CX Institutional Grows Stock Position in Cigna Group $CI

CX Institutional increased its position in shares of Cigna Group (NYSE:CI) by 20.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 25,582 shares of the health services provider’s stock after purchasing an additional 4,372 shares during the quarter. CX Institutional’s holdings in Cigna Group were worth $7,041,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CI. Brighton Jones LLC boosted its stake in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC boosted its stake in Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after buying an additional 109 shares during the period. NewEdge Advisors LLC boosted its stake in Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina boosted its stake in Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. purchased a new position in Cigna Group during the second quarter worth about $163,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Analysts Set New Price Targets

CI has been the subject of several research analyst reports. Mizuho set a $330.00 target price on shares of Cigna Group in a research note on Friday. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research note on Friday. Cantor Fitzgerald increased their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $336.20.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Up 0.1%

Shares of CI opened at $283.14 on Monday. The stock has a market capitalization of $74.62 billion, a PE ratio of 12.00, a P/E/G ratio of 0.98 and a beta of 0.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company’s 50-day simple moving average is $274.34 and its 200-day simple moving average is $276.63.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts forecast that Cigna Group will post 30.41 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.